Chosa Oncology AB (FRA:W5L)
0.0392
+0.0062 (18.79%)
At close: Nov 18, 2026
Chosa Oncology AB Market Cap
Chosa Oncology AB has a market cap or net worth of €3.58 million as of November 18, 2026. It is the 46,318th most valuable company in the world and the 610th biggest in Germany. Its market cap has decreased by 45.91% in one year.
Market Cap
3.58M
Enterprise Value
3.35M
Revenue
n/a
Global Rank
Country Rank
#610 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since August 28, 2023, Chosa Oncology AB's market cap has decreased from 4.53M to 3.58M, a decrease of -20.91%. That is a compound annual growth rate of -7.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 3.58M | -42.85% |
| Dec 30, 2025 | 6.27M | 72.04% |
| Dec 30, 2024 | 3.65M | 35.75% |
| Dec 29, 2023 | 2.69M | -40.74% |
| Aug 28, 2023 | 4.53M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.32B |
| Novogenia AG | 75.60M |
| 2invest AG | 37.71M |
| Biomark Diagnostics | 25.98M |
| Vidac Pharma Holding | 11.10M |
| Paion AG | 328.15K |
| bioXXmed AG | 254.19K |
| co.don AG | 133.62K |